Navigation Links
CIHR invests in Queen's-led study on end-of-life decision making
Date:2/6/2012

At a time when there is tremendous concern about the utilization of technology at the end of life and the costs of technology, the Canadian Institutes of Health Research (CIHR) has funded a multi-center study aimed to improve end of life decision making amongst seriously ill, elderly hospitalized patients. Queen's University is one institution receiving funding for this initiative.

"Canada's aging population is increasingly exposed to potentially unwanted technology at the end of life," says Daren Heyland, a professor of medicine at Queen's University, staff physician at Kingston General Hospital and Scientific Director of the Technology Evaluation in the Elderly Network. "Mounting evidence suggests that technology-laden end of life care is associated with poorer ratings of quality of life and increased family anxiety and depression. We need to understand what is happening currently, with respect to end of life decision-making, before we can improve things."

The DECIDE study looks at end of life care from the perspectives of hospital-based physicians and nurses examining barriers to communication about end of life care goals. Researchers will assess processes for improving decision making, while also exploring doctors' and nurses' views about their suitability for fulfilling the care goals with seriously ill hospitalized patients and their families.

Data will be collected from questionnaires distributed to over 1,000 staff physicians, residents and nurses from 12 hospitals across Canada, and from an additional 120 interviews involving front line staff. The results will form new strategies to improve communication and decision making.

The DECIDE study is a logical extension of Dr. Heyland's prior work, the ACCEPT study, wish is examining the same issues but from the patients' and families' perspectives.

The results of the ACCEPT study are being released April 16, National Advance Care Planning Day.

Both studies are funded by the Canadian Institutes of Health Research (CIHR).


'/>"/>

Contact: Anne Craig
anne.craig@queensu.ca
613-533-2877
Queen's University
Source:Eurekalert

Related medicine news :

1. Regence Invests in Kinetix Living Corp.
2. Philanthropist invests $3.5 million in Buck Institutes Alzheimers drug development effort
3. PGA invests in minority golf opportunities
4. Childhood asthma non-profit invests millions in health centers to help children better manage asthma
5. Harper government invests in personalized medicine
6. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
7. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
8. TV drama can be more persuasive than news program, study finds
9. Study carried out into biological risks of eating reptiles
10. Neuroimaging study may pave way for effective Alzheimers treatments
11. Study finds racial gaps continue in heart disease awareness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: